Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Announcements

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies

April 10, 2025

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for ...

Belgium, Mont Saint-Guibert, April 10 – Cellistic, a pioneer in induced pluripotent stem cells ...

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief Commercial Officer

March 10, 2025

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief ...

Mont-Saint-Guibert, Belgium (March 10, 2025) – Cellistic is pleased to announce the ...

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

February 17, 2025

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell ...

Belgium, Mont Saint-Guibert, February 17 – Cellistic, a pioneer in iPSC-based off-the-shelf ...

BrightPath Bio and Cellistic Announce Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

December 13, 2024

BrightPath Bio and Cellistic Announce Process Development and ...

Tokyo, Japan and Mont-Saint-Guibert, Belgium, – December 13th, 2024 BrightPath Bio (Tokyo ...

Cellistic Announces Successful Certification of its GMP Facility Dedicated to iPSC-based Cell Therapies

November 21, 2024

Cellistic Announces Successful Certification of its GMP Facility Dedicated ...

Belgium, Mont-Saint-Guibert, November 21, 2024 – Cellistic®, a pioneer in iPSC-based ...

Cellistic Announces Successful CRISPR intellectual property Asset Purchase

April 4, 2024

Cellistic Announces Successful CRISPR intellectual property Asset Purchase

Mont-Saint-Guibert, Belgium (April 4, 2023) – ACQUIRED ASSETS FROM ARTISAN BIO INCLUDE ...

1 2 3 →
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy